Genadyne Biotechnologies Expands Into Canadian Health Care Market, with New Distribution Center in Ontario

GREAT NECK, NY, January 14, 2011 (Press-News.org) Continuing its growth path, Genadyne Biotechnologies expands its services and products into the Canadian market. Headquartered out of Ontario, Genadyne Canada is bringing Genadyne's suite of specialty mattresses, and its Advanced Negative Pressure Wound Therapy the XLR8 to help reduce and treat wound occurrence.

"With the introduction of our new disposables in NWPT and the launch of the revolutionary Nefes non-power air system, timing could not have been better," said Shahzad Pirzada, President of Genadyne.

Genadyne's growth successful growth plan has been supported by products, service and educational platforms while helping reduce healthcare costs.

Genadyne Biotechnologies Inc. is a US based developer and manufacturer of negative pressure wound therapy systems, non-powered and powered pressure relieving therapeutic surfaces. The mission of Genadyne is to promote wound healing, decrease wound recurrence and maintain the dignity, independence, and comfort and pain control of the wound care patient through our products and through education.

Shahzad has 14 years of experience developing and bring to the market a wide array of respiratory products -- primarily CPAP and BIPAP technologies and portable oxygen delivering systems. Shahzad is a founder of Genadyne Biotechnologies, Inc., an international company with distributors across North America and Europe. He holds 11 patents - and - multiple-pending on air flotation surfaces, non-powered air surfaces, wireless weight scale systems and blood circulation devices. Shahzad is a pilot by training, with a background in avionics and aeronautical engineering from The College of Aeronautics in New York.

Website: http://www.genadyne.com/